 |
市場調查報告書
商品編碼
1629625
鐮狀細胞性貧血測試和篩檢市場：依測試方法、按年齡層、按行業、按地區Sickle Cell Anemia Testing and Screening Market, By Testing Method (Hemoglobin Electrophoresis, High-Performance Liquid Chromatography, Point-of-Care Tests, Genetic Testing, and Others), By Age Group, By Sector, By Geography |
||||||
預計2024年全球鐮狀細胞貧血檢測和篩檢市場規模為4.652億美元，預計到2031年將達到10.281億美元，2024年至2031年的複合年成長率為12%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 4.652 億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 預測 2024-2031 年複合年成長率： | 12.00% | 2031年價值預測 | 10.281 億美元 |
鐮狀細胞性貧血是一種遺傳性血液疾病，其中紅血球變成C形或鐮狀。鐮狀細胞性貧血是一組紅血球畸形導致貧血的疾病。這種疾病在撒哈拉以南非洲、拉丁美洲、中美洲和印度血統的人中更為常見。隨著全球移民和旅行的增加，這種疾病在不同人群中的盛行率也在增加。早期篩檢計畫可以幫助控制這種疾病，並透過終身治療和監測預防併發症。
市場動態：
全球鐮狀細胞性貧血檢測和篩檢市場是由這種遺傳性血液疾病在全球範圍內日益流行所推動的。 2021年10月，世界衛生組織(WHO)估計，每年有超過30萬名兒童出生時患有鐮狀細胞性貧血。高風險族群意識的提高以及將篩檢納入產前檢測正在為市場創造利潤豐厚的機會。然而，新興市場的低採用率和認知度繼續限制市場成長。精準醫療和非侵入性檢測技術的發展將有助於克服挑戰並在預測期內進一步擴大市場範圍。
本研究的主要特點
該報告對全球鐮狀貧血檢測和篩檢市場進行了詳細分析，並介紹了以 2023 年為基準年的預測期（2024-2031 年）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、績效和策略等參數，了解全球鐮狀鐮狀貧血測試和篩檢市場的主要企業概況。
本研究涵蓋的主要企業包括 Bio-Rad Laboratories, Inc.、Thermo Fisher Scientific Inc.、Quest Diagnostics Incorporated、Agios Pharmaceuticals, Inc.、Bluebird bio, Inc.、PerkinElmer, Inc.、Laboratory Corporation of America Holdings、Global Blood Therapeutics, Inc.、Edvotek Inc.、Maternova Inc.、Hemex Health、CRISPR Therapeutics、Anamol Laboratories Pvt.有限公司、Atlas Medical GmbH 和 Calibre Scientific, Inc.
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球鐮狀細胞性貧血測試和篩檢市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球鐮狀細胞貧血測試和篩檢市場的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章 市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要進展
- 監管場景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
- 產業動態
第 4 章 2019-2031 年鐮狀貧血檢測與篩檢的全球市場（依檢測方法）
- 血紅素電泳
- 高效液相層析（HPLC）
- 就地檢驗
- 基因檢測
- 其他
第五鐮狀鐮狀細胞性貧血檢測和篩檢的全球市場（按年齡層），2019-2031 年
- 新生兒篩檢
- 1-25歲
- 26歲或以上
第6章 2019-2031 年全球鐮狀細胞貧血檢測與篩檢市場（依產業分類）
- 政府實驗室
- 私人研究所
- 企業研究院
- 官民合作關係(PPP)
第7章2019-2031 年全球鐮狀細胞貧血檢測與篩檢市場（按地區）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第8章 競爭格局
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Agios Pharmaceuticals, Inc.
- Bluebird bio, Inc.
- PerkinElmer, Inc.
- Laboratory Corporation of America Holdings
- Global Blood Therapeutics, Inc.
- Edvotek Inc.
- Maternova Inc.
- Hemex Health
- CRISPR Therapeutics
- Anamol Laboratories Pvt. Ltd.
- Atlas Medical GmbH
- Calibre Scientific, Inc.
第9章 分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第10章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
The global sickle cell anemia testing and screening market is estimated to be valued at USD 465.2 Mn in 2024 and is expected to reach USD 1,028.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 12% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 465.2 Mn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 12.00% | 2031 Value Projection: | US$ 1,028.1 Mn |
Sickle cell anemia is a genetic blood disorder that affects the red blood cells and causes them to take on a C-like or sickle shape. It is a group of disorders that causes the red blood cells to become misshapen and break down leasing to anemia. The disorder is more common in those with ancestry from sub-Saharan Africa, Latin America, Central America, and India. With increased immigration and travel globally, its prevalence has increased in diverse populations as well. Early screening programs can help in the management of the condition and prevent complications through lifelong treatment and monitoring.
Market Dynamics:
The global sickle cell anemia testing and screening market is driven by the increasing prevalence of the genetic blood disorder globally. In October 2021, as per the World Health Organization (WHO), it is estimated that over 300,000 children are born with sickle cell anemia each year. Growing awareness among at-risk populations and incorporating screening in prenatal testing are providing lucrative opportunities in the market. However, lower adoption and awareness levels in developing regions continues to restrain the market growth. Developments in precision medicine and non-invasive testing techniques can help overcome challenges and further expand the market reach during the forecast period.
Key Features of the Study:
This report provides in-depth analysis of the global sickle cell anemia testing and screening market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sickle cell anemia testing and screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Agios Pharmaceuticals, Inc., Bluebird bio, Inc., PerkinElmer, Inc., Laboratory Corporation of America Holdings, Global Blood Therapeutics, Inc., Edvotek Inc., Maternova Inc., Hemex Health, CRISPR Therapeutics, Anamol Laboratories Pvt. Ltd., Atlas Medical GmbH, and Calibre Scientific, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sickle cell anemia testing and screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sickle cell anemia testing and screening market
Market Segmentation
- By Testing Method Insights (Revenue, USD Mn, 2019 - 2031)
- Hemoglobin Electrophoresis
- High-Performance Liquid Chromatography (HPLC)
- Point-of-Care Tests
- Genetic Testing
- Others
- By Age Group Insights (Revenue, USD Mn, 2019 - 2031)
- Newborn Screening
- Ages 1 to 25
- Ages 26 and Above
- By Sector Insights (Revenue, USD Mn, 2019 - 2031)
- Government Labs
- Private Labs
- Corporate Labs
- PPP (Public Private Partnerships)
- Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Agios Pharmaceuticals, Inc.
- Bluebird bio, Inc.
- PerkinElmer, Inc.
- Laboratory Corporation of America Holdings
- Global Blood Therapeutics, Inc.
- Edvotek Inc.
- Maternova Inc.
- Hemex Health
- CRISPR Therapeutics
- Anamol Laboratories Pvt. Ltd.
- Atlas Medical GmbH
- Calibre Scientific, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Sickle Cell Anemia Testing and Screening Market, By Testing Method
- Global Sickle Cell Anemia Testing and Screening Market, By Age Group
- Global Sickle Cell Anemia Testing and Screening Market, By Sector
- Global Sickle Cell Anemia Testing and Screening Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Sickle Cell Anemia Testing and Screening Market, By Testing Method, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hemoglobin Electrophoresis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- High-Performance Liquid Chromatography (HPLC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Point-of-Care Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global Sickle Cell Anemia Testing and Screening Market, By Age Group, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Newborn Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Ages 1 to 25
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Ages 26 and Above
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Sickle Cell Anemia Testing and Screening Market, By Sector, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Government Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Private Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Corporate Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Public Private Partnerships (PPP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Sickle Cell Anemia Testing and Screening Market, By Region, 2019 - 2031, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country /Region, 2019 - 2031, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agios Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bluebird bio, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Laboratory Corporation of America Holdings
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Global Blood Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Edvotek Inc.
- Maternova Inc.
- Hemex Health
- CRISPR Therapeutics
- Anamol Laboratories Pvt. Ltd.
- Atlas Medical GmbH
- Calibre Scientific, Inc.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
